Stephen F. Mahoney - Net Worth and Insider Trading

Stephen F. Mahoney Net Worth

The estimated net worth of Stephen F. Mahoney is at least $9,979 dollars as of 2024-04-29. Stephen F. Mahoney is the See Remarks of Magenta Therapeutics Inc and owns about 14,264 shares of Magenta Therapeutics Inc (MGTA) stock worth over $9,979. Details can be seen in Stephen F. Mahoney's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen F. Mahoney has not made any transactions after 2021-09-16 and currently still holds the listed stock(s).

Transaction Summary of Stephen F. Mahoney

To

Stephen F. Mahoney Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen F. Mahoney owns 3 companies in total, including Kiniksa Pharmaceuticals Ltd (KNSA) , Magenta Therapeutics Inc (MGTA) , and Viridian Therapeutics Inc (VRDN) .

Click here to see the complete history of Stephen F. Mahoney’s form 4 insider trades.

Insider Ownership Summary of Stephen F. Mahoney

Ticker Comapny Transaction Date Type of Owner
KNSA Kiniksa Pharmaceuticals Ltd 2018-05-23 10 percent owner & President & COO
MGTA Magenta Therapeutics Inc 2021-09-16 See Remarks
VRDN Viridian Therapeutics Inc 2023-10-30 director & President and CEO

Stephen F. Mahoney Latest Holdings Summary

Stephen F. Mahoney currently owns a total of 1 stock. Stephen F. Mahoney owns 14,264 shares of Magenta Therapeutics Inc (MGTA) as of September 16, 2021, with a value of $9,979.

Latest Holdings of Stephen F. Mahoney

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MGTA Magenta Therapeutics Inc 2021-09-16 14,264 0.70 9,979

Holding Weightings of Stephen F. Mahoney


Stephen F. Mahoney Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen F. Mahoney has made a total of 1 transactions in Magenta Therapeutics Inc (MGTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Magenta Therapeutics Inc is the sale of 5,736 shares on September 16, 2021, which brought Stephen F. Mahoney around $38,603.

Insider Trading History of Stephen F. Mahoney

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen F. Mahoney Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephen F. Mahoney Ownership Network

Ownership Network List of Stephen F. Mahoney

No Data

Ownership Network Relation of Stephen F. Mahoney


Stephen F. Mahoney Owned Company Details

What does Kiniksa Pharmaceuticals Ltd do?

Who are the key executives at Kiniksa Pharmaceuticals Ltd?

Stephen F. Mahoney is the 10 percent owner & President & COO of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Accounting Officer Michael R Megna , and Chief Medical Officer John Paolini .

Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary

Over the past 18 months, Stephen F. Mahoney made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .

In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.

Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiniksa Pharmaceuticals Ltd Insider Transactions

No Available Data

Stephen F. Mahoney Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen F. Mahoney. You might contact Stephen F. Mahoney via mailing address: C/o Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton D0 Hm11.

Discussions on Stephen F. Mahoney

No discussions yet.